Expert Panel: Role of Genomics and Genetics in Prostate Cancer

Christopher Lee, MD; Alvaro Martinez, MD; Daniel Kim, MD, MBA; Steven E. Finkelstein, MD, and Dwight E. Heron, MD, MBA, FACRO, FACR discuss how, genomic and genetic research is revolutionizing our understanding of prostate cancer risk, progression, personalized treatment strategies, and potential targeted interventions by identifying specific genetic markers, inherited mutations, and molecular pathways that influence disease development and patient outcomes.